GEN Exclusives

More »

GEN News Highlights

More »
Sep 20, 2006

Solexa Secures Two-Year Equity Financing Commitment

  • Solexa secured a two-year commitment for up to $75 million in a common stock equity financing from Azimuth Opportunity. Solexa intends to use the net proceeds from the financing for the development and commercialization of the Solexa Genome Analysis System, working capital, and other general corporate purposes.

    During the term of this commitment, Solexa may sell registered shares of its common stock to Azimuth at a small discount to the market price. Solexa will determine the timing and amount of any sales of its stock.

    The shares are being offered pursuant to an effective registration statement filed with the SEC.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?